Stay updated with breaking news from Adjuvant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda , Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of... | April 6, 2023
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trialCAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / February 22, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering
The German Working Group for Covid Vaccine Analysis – which includes over 60 scientists, doctors, lawyers, and journalists – published their “Summary of Preliminary Findings” on the toxic [...]
Low score suggests improved outcomes with ovarian suppression plus adjuvant endocrine therapy
First-in-human study investigating the safety and immunogenicity of ISA's proprietary Amplivant adjuvant conjugated to human papillomavirus type 16 (HPV16) Synthetic Long Peptides (SLPs). SLPs